October 22, 2021
Company Info
| Industry | Medical Specialties |
|---|---|
| Sector | Health Technology |
| Employees | 575 |
| CEO | Ms. Caren L. Mason |
| Address | 25651 Atlantic Ocean Drive , Lake Forest, CA 92630 |
|---|---|
| Phone | 1.626.303.7902 |
| Website | www.staar.com |
STAAR Surgical Co. engages in the development, manufacture, production, marketing, and sale of implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. It specializes in refractive and cataract solutions. Its products include intraocular lens and implantable collamer lens. The company was founded in 1982 and is headquartered in Lake Forest, CA.
Competitors
| Company Name | 3 Month %Change |
1 Year %Change |
|---|---|---|
| STAAR Surgical Co. | -6.19% | 72.09% |
| Intellia Therapeutics, Inc. | -12.14% | 457.34% |
| Neurocrine Biosciences, Inc. | 6.47% | 7.33% |
| Zai Lab Ltd. | -36.13% | 18.35% |
| Mirati Therapeutics, Inc. | 8.04% | -1.38% |
Statement Summary
as of 4:00 ET PM 10/21/2021| Total Assets (MRQ) | 294.4 M |
|---|---|
| Total Liabilities (MRQ) | 59.8 M |
| Shareholders’ Equity (MRQ) | 234.6 M |
| Total Revenue (Annual) | 62.4 M |
| Net Income (Annual) | 8.6 M |
Earnings And Estimates
as of 4:00 ET PM 10/21/2021
| Current Qtr EPS Estimate | 0.17 |
|---|---|
| Current FY EPS Estimate | 0.80 |
| Long Term EPS Growth Estimate | 17.50 |
| Next Expected Earnings Date | // |
STAA vs S&P 500
as of 10/21/2021| Relative To S&P 500 |
STAA | |
|---|---|---|
| 4 Weeks | n/a | n/a |
| 12 Weeks | n/a | n/a |
| YTD | n/a | n/a |
Earnings Surprises
as of 4:00 ET PM 10/21/2021| Fiscal Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 06/2021 | 0.08 | 0.27 | +231.58% |
| 03/2021 | 0.03 | 0.20 | +500.01% |
| 12/2020 | 0.08 | 0.14 | +71.43% |
| 09/2020 | 0.09 | 0.14 | +61.54% |
| 06/2020 | 0.01 | 0.03 | +299.20% |
| 03/2020 | 0.03 | 0.04 | +53.85% |
| 12/2019 | 0.07 | 0.12 | +71.43% |
| 09/2019 | 0.09 | 0.12 | +29.73% |
Financial Strength
as of 4:00 ET PM 10/21/2021| Pre-Tax Margin | 17.18 |
|---|---|
| Net Margin | 0.00 |
| Operating Margin | 17.07 |
| Return On Equity | 10.15 |
| Return On Assets | 8.11 |
| Inventory Turnover (TTM) | 2.91 |
| Sales Growth (MRQ) | 16.21 |
Ratios
as of 4:00 PM ET 10/21/2021| Price/Earnings (TTM) | 297.88 |
|---|---|
| Price/Book (MRQ) | 25.48 |
| Price/Cash Flow (TTM) | 147.65 |
| Book Value (MRQ) | 4.95 |
| Quick Ratio (MRQ) | 5.56 |
| Current Ratio (MRQ) | 5.94 |
| Total Debt/Equity (MRQ) | 0.05 |
Short Interest
as of 12:25 PM ET 10/22/2021| % Short - 0.00% | |
| % Remaining Float - 100.00% |
| Current | Last Month | |
|---|---|---|
| Short Interest Date | n/a | n/a |
| Short Interest Shares | 0 | 0 |
| Short Interest Ratio | 0.0 | 0.0 |
M Y M Y
Total Assets 0,0.00 0,0.00
Total Liabilities 0,0.00 0,0.00
Total Equity 0,0.00 0,0.00
M Y M Y
Total Revenue 0,0.00 0,0.00
EBT Exc.
Unusual Items
0,0.00
0,0.00
Net Income 0,0.00 0,0.00
M Y M Y
Cash from
Operations
0,0.00
0,0.00
Cash from
Activities
0,0.00
0,0.00
Cash from
Fin. Activities
0,0.00
0,0.00
TOTAL ASSETS |
TOTAL LIABILITIES |
TOTAL EQUITY |
|---|---|---|
Balance Sheet
| M Y | ||||
|---|---|---|---|---|
| ASSETS | ||||
| Cash And Equivalents | 0,0.00 | |||
| Receivables | 0,0.00 | |||
| Inventories | 0,0.00 | |||
| Other Current Assets | 0,0.00 | |||
| Total Current Assets | 0,0.00 | |||
| Property, Plant & Equipment, Gross | 0,0.00 | |||
| Accumulated Depreciation & Depletion | 0,0.00 | |||
| Property, Plant & Equipment, Net | 0,0.00 | |||
| Intangibles | 0,0.00 | |||
| Other Non-Current Assets | 0,0.00 | |||
| Total Non-Current Assets | 0,0.00 | |||
| TOTAL ASSETS | 0,0.00 | |||
| Liabilities & Shareholder Equity | ||||
| Accounts Payable | 0,0.00 | |||
| Short Term Debt | 0,0.00 | |||
| Total Current Liabilities | 0,0.00 | |||
| Long Term Debt | 0,0.00 | |||
| Deferred Income Taxes | 0,0.00 | |||
| Other Non-Current Liabilities | 0,0.00 | |||
| Minority Interest | 0,0.00 | |||
| Total Non-Current Liabilities | 0,0.00 | |||
| Preferred Stock Equity | 0,0.00 | |||
| Common Stock Equity | 0,0.00 | |||
| Common Par | 0,0.00 | |||
| Additional Paid In Capital | 0,0.00 | |||
| Cumulative Translation Adjustment | 0,0.00 | |||
| Retained Earnings | 0,0.00 | |||
| Treasury Stock | 0,0.00 | |||
| Other Equity Adjustments | 0,0.00 | |||
| Total Capitalization | 0,0.00 | |||
| TOTAL EQUITY | 0,0.00 | |||
| TOTAL LIABILITIES & STOCK EQUITY | 0,0.00 | |||
| Total Common Shares Outstanding | 0,0.00 | |||
| Preferred Shares | 0,0.00 | |||
| Treasury Shares | 0,0.00 | |||
| Basic Weighted Shares Outstanding | 0,0.00 | |||
| Diluted Weighted Shares Outstanding | 0,0.00 | |||
| Number Of Employees | 0,0.00 | |||
| Number Of Part-Time Employees | 0,0.00 | |||
TOTAL REVENUES |
EBT Excluding Unusual Items |
NET INCOME |
|---|---|---|
Income Statement
| M Y | |
|---|---|
| Sales | 0,0.00 |
| Cost Of Sales | 0,0.00 |
| Gross Operating Profit | 0,0.00 |
| Selling, General, And Administrative Expenses | 0,0.00 |
| Research & Development | 0,0.00 |
| Operating Income Before D & A (EBITDA) | 0,0.00 |
| Depreciation & Amortization | 0,0.00 |
| Interest Income | 0,0.00 |
| Other Income - Net | 0,0.00 |
| Special Income / Charges | 0,0.00 |
| Total Income Before Interest Expenses (EBIT) | 0,0.00 |
| Interest Expense | 0,0.00 |
| Pre-Tax Income | 0,0.00 |
| Income Taxes | 0,0.00 |
| Minority Interest | 0,0.00 |
| Net Income From Continuing Operations | 0,0.00 |
| Net Income From Discontinued Operations | 0,0.00 |
| Net Income From Total Operations | 0,0.00 |
| Extraordinary Income/Losses | 0,0.00 |
| Income From Cum. Effect Of Acct. Change | 0,0.00 |
| Income From Tax Loss Carryforward | 0,0.00 |
| Other Gains / Losses | 0,0.00 |
| Total Net Income | 0,0.00 |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
0,0.00 |
| Preferred Dividends | 0,0.00 |
| Net Income Available To Common | 0,0.00 |
| Basic EPS From Continuing Ops. | 0,0.00 |
| Basic EPS From Discontinued Ops. | 0,0.00 |
| Basic EPS From Total Operations | 0,0.00 |
| Basic EPS From Extraordinary Inc. | 0,0.00 |
| Basic EPS From Cum Effect Of Accounting Change | 0,0.00 |
| Basic EPS From Tax Loss Carryf'd. | 0,0.00 |
| Basic EPS From Other Gains (Losses) | 0,0.00 |
| Basic EPS, Total | 0,0.00 |
| Basic Normalized Net Income/Share | 0,0.00 |
| EPS From Continuing Ops. | 0,0.00 |
| EPS From Discontinued Ops | 0,0.00 |
| EPS From Total Ops. | 0,0.00 |
| EPS From Extraord. Inc. | 0,0.00 |
| EPS From Cum Effect of Accounting Change | 0,0.00 |
| EPS From Tax Loss Carfd. | 0,0.00 |
| EPS From Other Gains (L) | 0,0.00 |
| EPS, Total | 0,0.00 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
0,0.00 |
| Dividends Paid Per Share | 0,0.00 |
CASH FROM OPERATIONS |
CASH FROM INVESTING ACTIVITIES |
CASH FROM FINANCING ACTIVITIES |
|---|---|---|
Cash Flow Statement
| M Y | ||||
|---|---|---|---|---|
| Cash Flow From Operating Activities | ||||
| Net Income (Loss) | 0,0.00 | |||
| Operating Gains/Losses | 0,0.00 | |||
| Gross Operating Profit | 0,0.00 | |||
| (Increase) Decrease In Receivables | 0,0.00 | |||
| (Increase) Decrease In Inventories | 0,0.00 | |||
| (Increase) Decrease In Other Current Assets | 0,0.00 | |||
| (Decrease) Increase In Other Current Liabilities | 0,0.00 | |||
| (Increase) Decrease In Other Working Capital | 0,0.00 | |||
| Other Non-Cash Items | 0,0.00 | |||
| Net Cash From Continuing Operations | 0,0.00 | |||
| Net Cash From Discontinued Operations | 0,0.00 | |||
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | 0,0.00 | |||
| Sale Of Property, Plant & Equipment | 0,0.00 | |||
| Cash Used For Investing Activities | ||||
| Sale Of Short-Term Investments | 0,0.00 | |||
| Purchases Of Property, Plant & Equipment | 0,0.00 | |||
| Acquisitions | 0,0.00 | |||
| Purchases Of Short-Term Investments | 0,0.00 | |||
| Other Cash From Investing Activities | 0,0.00 | |||
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | 0,0.00 | |||
| Issuance Of Debt | 0,0.00 | |||
| Cash Used For Financing Activities | ||||
| Issuance Of Capital Stock | 0,0.00 | |||
| Repayment Of Long-Term Debt | 0,0.00 | |||
| Repurchase Of Capital Stock | 0,0.00 | |||
| Payment Of Cash Dividends | 0,0.00 | |||
| Other Financing Charges, Net | 0,0.00 | |||
| Net Cash From Financing Activities | 0,0.00 | |||
| Effect Of Exchange Rate Changes | 0,0.00 | |||
| Net Change In Cash & Cash Equivalents | 0,0.00 | |||
Earnings Estimates
as of 4:00 ET PM 10/21/2021| Current Qtr (09/2021) |
Next Qtr (12/2021) |
|
|---|---|---|
| Consensus Estimate | $0.17 | $0.17 |
| # of Estimates | 6 | 6 |
| High Estimate | $0.19 | $0.18 |
| Low Estimate | $0.15 | $0.15 |
| Year Ago EPS | $0.08 | $0.07 |
| Year Over Year Growth Estimate | 96.54% | 131.80% |
| Current Yr (12/2021) |
Next Yr (12/2022) |
|
|---|---|---|
| Consensus Estimate | $0.80 | $0.93 |
| # of Estimates | 6 | 6 |
| High Estimate | $0.83 | $1.10 |
| Low Estimate | $0.73 | $0.80 |
| Year Ago EPS | $0.35 | $0.80 |
| Year Over Year Growth Estimate | 127.62% | 17.15% |
| Current Qtr (09/2021) |
Next Qtr (12/2021) |
Current Year (12/2021) |
Next Year (12/2022) |
|
|---|---|---|---|---|
| Consensus Estimate | $0.17 | $0.17 | $0.80 | $0.93 |
| # of Estimates | 6 | 6 | 6 | 6 |
| High Estimate | $0.19 | $0.18 | $0.83 | $1.10 |
| Low Estimate | $0.15 | $0.15 | $0.73 | $0.80 |
| Year Ago EPS | $0.08 | $0.07 | $0.35 | $0.80 |
| Year Over Year Growth Estimate | 96.54% | 131.80% | 127.62% | 17.15% |
Insider Information Summary
as of 09/30/2021| % Insiders - 0.80% | |
| % Remaining Total Shares - 99.20% |
| Current | 1 Month | |
|---|---|---|
| Net Insider Transaction | -34.34 K | -610.79 K |
| Shares Bought | 143.77 K | 86.34 K |
| Shares Sold | 178.11 K | 697.13 K |
Insider Activity
| Transaction Date | Insider/Title | Transaction Type | Market Value | Shares | Average Price | Current Holdings | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Learn to Trade Like a Pro
Master The Market with the Help of Our Financial Experts
LATEST NEWS
Latest News
STAAR Surgical To Report Second Quarter Results On August 4, 2021
Jul 21, 2021 9:15 AM EDT
STAAR Surgical To Report First Quarter Results On May 5, 2021
Apr 21, 2021 7:00 AM EDT
STAAR Surgical To Report Fourth Quarter And Fiscal Year Results On February 24, 2021
Feb 10, 2021 7:00 AM EST
Elizabeth Yeu, M.D. And K. Peony Yu, M.D. Appointed To STAAR Surgical Board Of Directors
Jan 26, 2021 10:45 AM EST
STAAR Surgical Announces Preliminary Fourth Quarter And Full Year 2020 Results
Jan 10, 2021 6:00 PM EST
Local Language EVO Viva™ Website. (Graphic: Business Wire)
Nov 4, 2020 4:03 PM EST
STAAR Surgical To Report Third Quarter Results On November 4, 2020
Oct 21, 2020 7:00 AM EDT
STAAR Surgical To Participate In Upcoming Investor Conferences
Sep 2, 2020 7:00 AM EDT
Recent Articles from TheStreet
CDC Clears Mix-And-Match Booster Shots for Moderna and J&J
A CDC director has signed off on extra doses, and on taking a Covid booster different from the original vaccine, in line with the U.S. FDA recommendations.
Simon Property Target Price Up as Bank of America Sees Catalysts
Simon Property firmed after Bank of America increased its price target for the country’s biggest shopping mall REIT to $165 from $150.
5 Top Stock Decliners for Friday: Snap, Beyond Meat, Intel
Snap, Intel, Moderna, Beyond Meat and Honeywell are five stocks that fell on Friday.
Intel Stock: One Thing Stands Between It and Another 11% Decline
Intel stock is dropping after its earnings report, but a further 11% decline could be in the cards unless Intel holds a key support level.
Ocular Therapeutix Stock Slumps; Dry-Eye Drug Misses Trial Endpoint HOLD
Ocular Therapeutix shares lost a third of their market value after the biopharma's candidate for dry-eye disease missed its key endpoint.
Stocks Mixed as Powell Cautions on Inflation, Taper Plan on Track
Stocks are mixed as Fed Chair Powell said the central bank was on track to begin tapering the pace of its monthly bond purchases.
5 Top Gainers for Friday: WeWork, Cleveland-Cliffs, American Express
WeWork, Cleveland-Cliffs, American Express, Phunware and Olin are five top gainers for Friday.
Carvana Drops; Complaints Against Car Retailer Reportedly at Issue
The Better Business Bureau has received nearly 900 consumer complaints about Carvana this year, a media report says.
Buy the Dip in Beyond Meat Stock? Not So Fast.
Beyond Meat stock is slumping on Friday after slashing its revenue outlook. The charts don't look great -- unless it can reclaim a key level.
Seagate Shares Rise on Stronger-Than-Expected Earnings
Seagate Technology shares rose after the disk-drive maker reported stronger-than-expected earnings and buoyant guidance.
CLOSE
CLOSE
CLOSE
CLOSE